Related Experiment Video
Updated: Jul 23, 2025
09:43
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
9.2K
Targeting Metabolic Vulnerabilities in Epstein-Barr Virus-Driven Proliferative Diseases.
Nicole Yong Ting Leung1, Liang Wei Wang1
1Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore 138648, Singapore.
Cancers
|July 14, 2023
Summary
Cancer cells and Epstein-Barr virus (EBV) infected cells share similar metabolic reprogramming. Understanding these metabolic changes can reveal new therapeutic targets for EBV-associated cancers.
Area of Science:
- Oncology
- Virology
- Metabolic research
Background:
- Cancer cells reprogram metabolism for proliferation and metastasis.
- Epstein-Barr virus (EBV) manipulates host metabolism for viral replication and transmission.
- EBV is linked to approximately 1% of human cancers.
Purpose of the Study:
- To review metabolic alterations induced by EBV.
- To explore the impact of these metabolic changes on EBV-associated diseases.
- To discuss therapeutic strategies targeting metabolic vulnerabilities.
Main Methods:
- Literature review of research on EBV and cellular metabolism.
- Analysis of metabolic pathways in EBV-infected cells and cancer cells.
- Synthesis of current and potential treatment options.
Main Results:
- Significant similarities exist between cancer cell and EBV-infected cell metabolism.
- EBV hijacks host metabolic pathways to support its lifecycle and oncogenesis.
- Metabolic reprogramming is crucial for EBV-driven cancer development.
Conclusions:
- Understanding EBV-induced metabolic changes is key to developing novel cancer therapies.
- Targeting metabolic vulnerabilities offers a promising approach for treating EBV-associated malignancies.
- Nutritional interventions may play a role in reducing the burden of these diseases.
